No Difference Between Low- and Regular-dose Aspirin for Venous Thromboembolism Prophylaxis After THA.

CONCLUSIONS: We found no difference in the incidence of symptomatic VTE after THA with low-dose compared with standard-dose aspirin. In the absence of compelling evidence to the contrary, low-dose aspirin appears to be a reasonable option for VTE prophylaxis in otherwise healthy patients undergoing elective THA.
LEVEL OF EVIDENCE: Level III, therapeutic study.
PMID: 30624322 [PubMed - as supplied by publisher]

Source: Clinical Orthopaedics and Related Research - January 4, 2019 Category: Orthopaedics Authors: Faour M, Piuzzi NS, Brigati DP, Klika AK, Mont MM, Barsoum WK, Higuera-Rueda C Tags: Clin Orthop Relat Res Source Type: research